Several executive orders recently signed by US President Donald Trump may have significant implications for the US Food and Drug Administration ...
MyChesCo on MSN1h
FDA Approves First-in-Class Non-Opioid Pain Drug JournavxThe U.S. Food and Drug Administration (FDA) has approved Journavx (suzetrigine) 50 milligram oral tablets, a groundbreaking ...
By JESSE BEDAYN Associated Press/Report for America President Donald Trump's plan to impose tariffs on goods from Mexico, ...
Amid the uproar over the firing of 18 inspectors general, a report offering a coda to the aducanumab approval episode has ...
A Boston-area biopharmaceutical firm has submitted a biologics license application to the FDA for its investigational, fully ...
Less than two months after an accelerated approval from the FDA, a drug combination featuring Pfizer’s Braftovi has turned in ...
The next big advance in treating diseases like rheumatoid arthritis could be tiny pulses of electricity delivered to the ...
Trump's pick for HHS secretary who endured confirmation hearings last week—has repeatedly criticized industry ties to the FDA ...
You'll get access to an ad-free website with a faster photo browser, the chance to claim free tickets to a host of events (including everything from Summerfest to the Milwaukee Film Festival), access ...
As secretary of the HHS, Kennedy would oversee major health agencies, including the Food and Drug Administration (FDA), the ...
The drug, shown to be almost as effective as opioids for short-term pain, is the first fundamentally new kind of painkiller ...
The FDA’s framework for AI regulation, while robust for premarket evaluation, would benefit from more specific mechanisms for continuous monitoring of AI performance in diverse real-world settings.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback